This is a lovely story, and I enjoyed reading it. I'm not sure the infection of haemophiliacs from blood products should be compared to Grenfell. Unlike alumi

This is a lovely story, and I enjoyed reading it. I'm not sure the infection of haemophiliacs from blood products should be compared to Grenfell. Unlike aluminium cladding on a skyscraper, patients took factor concentrate on specific medical advice to treat bleeds that would otherwise not have stopped. These factor concentrates required hundreds of blood transfusions to make just a small amount (they were also highly expensive, and still are today, shots can easily cost several thousands of pounds each), and they were given to treat bleeds, which were life-threatening or limb-threatening. In younger children and severe haemophiliacs they had to be given factor regularly to prevent bleeds. The enquiry will need to look at how the pharmaceutical/product companies and health organisations dealt with incoming information, and whether they had a viable alternative at the time. There is suggestion that the UK producer of factor concentrate (BPL) was highly underfunded at the time, and unable to produce the required amount of factor concentrate to supply the country. There is a UK public enquiry ongoing to assess whether someone or some organisation should hold responsibility for it - and I agree it is overdue.